Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q1 2021 · 10-Q
Revenue$12.33M$12.33M+21.5% vs Q1 2020 Net Income-$9.40M-$9.40MN/M vs Q1 2020 EPS Diluted-$0.18-$0.18N/M vs Q1 2020 Gross Profit$8,898,028+38.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flow-$2,192,038N/M Free Cash Flowderived-$2,285,332N/M Margins · derivedGross margin72.2%+8.6 pt vs Q1 2020
Operating margin-14.3%+46.0 pt vs Q1 2020
Net margin-76.2%
ended Dec 31, 2020 · filed Feb 9, 2021 · 40 d after period end